| Description |
methyl-CpG binding domain 4, DNA glycosylase |
N-acetyltransferase 2 |
| Image |
|
|
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
|
| Diseases |
|
|
| GWAS |
- Diisocyanate-induced asthma ( 25918132)
- Systemic sclerosis (anti-topoisomerase-positive) ( 29293537)
- Waist-hip index ( 34021172)
- Waist-to-hip ratio adjusted for BMI ( 34021172 26426971)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
|
- Apolipoprotein A1 levels ( 32203549)
- Apolipoprotein B levels ( 32203549)
- Bladder cancer ( 24163127 20972438)
- Blood metabolite levels ( 24816252)
- Blood metabolite ratios ( 24816252)
- Cholesterol, total ( 24097068 20686565)
- Coronary artery disease ( 29212778 33020668)
- Gut microbiota (bacterial taxa, hurdle binary method) ( 32572223)
- Insulin resistance/response ( 25798622)
- Iron status biomarkers (total iron binding capacity) ( 33536631)
- Iron status biomarkers (transferrin levels) ( 25352340)
- LDL cholesterol levels ( 32203549)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Liver enzyme levels (alkaline phosphatase) ( 33972514)
- Liver enzyme levels (gamma-glutamyl transferase) ( 33972514)
- Liver injury in anti-tuberculosis drug treatment ( 31109976)
- Medication use (calcium channel blockers) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Metabolic syndrome ( 31589552)
- Metabolic traits ( 21886157)
- Metabolite levels ( 23823483)
- Myocardial infarction ( 33532862)
- Night sleep phenotypes ( 27126917)
- Paclitaxel-induced neuropathy ( 23776197)
- Serum metabolite levels ( 33031748)
- Total cholesterol levels ( 28334899 33339817)
- Triglyceride levels ( 32203549 28334899 29403010 33339817 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x long total sleep time interaction (2df test) ( 31719535)
- Triglyceride levels x short total sleep time interaction (2df test) ( 31719535)
- Triglycerides ( 24097068 20686565)
- Urinary metabolite levels in chronic kidney disease ( 31959995)
- Urinary metabolite modules (eigenmetabolites) in chronic kidney disease ( 31959995)
- Urinary metabolites ( 26352407 21572414)
- Urinary metabolites (H-NMR features) ( 24586186)
- Youthful appearance (self-reported) ( 32339537)
|
| Interacting Genes |
16 interacting genes:
CDCA2
CSNK2B
DNMT3B
EPHB1
FADD
FAS
HDAC1
KDM1A
MLH1
NAT2
SIN3A
SUV39H1
TRIM27
TRIM55
TRIM63
UHRF1
|
18 interacting genes:
APC
APP
AURKA
BAG4
CDKN2A
CDKN2C
CLU
ERBB2
FZR1
HMMR
IGF1R
MBD4
NAA10
NBN
PALB2
PPM1D
STK11
WT1
|
| Entrez ID |
8930 |
10 |
| HPRD ID |
04654 |
02000 |
| Ensembl ID |
ENSG00000129071
|
ENSG00000156006
|
| Uniprot IDs |
O95243
|
A4Z6T7
P11245
|
| PDB IDs |
2MOE
3IHO
4DK9
4E9E
4E9F
4E9G
4E9H
4EA4
4EA5
4LG7
4OFA
4OFE
4OFH
5CHZ
6VJW
|
2PFR
|
| Enriched GO Terms of Interacting Partners? |
|
|
| Tagcloud ? |
|
|
| Tagcloud (Difference) ? |
|
|
| Tagcloud (Intersection) ? |
|